Published in J Pediatr on December 06, 2014
Quantitative herpes simplex virus concentrations in neonatal infection. J Pediatr (2015) 0.75
Neonatal Herpes Simplex Viral Infections and Acyclovir: An Update. J Pediatr Pharmacol Ther (2017) 0.75
Treatment of perinatal viral infections to improve neurologic outcomes. Pediatr Res (2016) 0.75
Comparison of Western blot (immunoblot) and glycoprotein G-specific immunodot enzyme assay for detecting antibodies to herpes simplex virus types 1 and 2 in human sera. J Clin Microbiol (1988) 8.09
Genital herpes simplex virus infections: clinical manifestations, course, and complications. Ann Intern Med (1983) 7.89
Persistence of HIV-1 receptor-positive cells after HSV-2 reactivation is a potential mechanism for increased HIV-1 acquisition. Nat Med (2009) 4.03
Polymerase chain reaction for detection of herpes simplex virus (HSV) DNA on mucosal surfaces: comparison with HSV isolation in cell culture. J Infect Dis (2003) 3.19
Quantitative stability of DNA after extended storage of clinical specimens as determined by real-time PCR. J Clin Microbiol (2002) 2.83
Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet (1988) 2.54
Optimizing PCR positivity criterion for detection of herpes simplex virus DNA on skin and mucosa. J Clin Microbiol (2007) 2.42
Immune surveillance by CD8αα+ skin-resident T cells in human herpes virus infection. Nature (2013) 2.38
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics (2001) 2.30
Evolution of recurrent herpes simplex lesions. An immunohistologic study. J Clin Invest (1985) 2.28
Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med (2011) 2.18
Time course of seroconversion by HerpeSelect ELISA after acquisition of genital herpes simplex virus type 1 (HSV-1) or HSV-2. Sex Transm Dis (2003) 1.92
Differentiation of herpes simplex virus types 1 and 2 in clinical samples by a real-time taqman PCR assay. J Med Virol (2005) 1.81
Changing presentation of herpes simplex virus infection in neonates. J Infect Dis (1988) 1.76
A controlled trial comparing vidarabine with acyclovir in neonatal herpes simplex virus infection. Infectious Diseases Collaborative Antiviral Study Group. N Engl J Med (1991) 1.73
Clinical correlates of herpes simplex virus viremia among hospitalized adults. Clin Infect Dis (2009) 1.69
Application of the polymerase chain reaction to the diagnosis and management of neonatal herpes simplex virus disease. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis (1996) 1.66
Diagnosis of herpes simplex virus by direct immunofluorescence and viral isolation from samples of external genital lesions in a high-prevalence population. J Clin Microbiol (1987) 1.64
Herpes simplex virus infection in pregnancy and in neonate: status of art of epidemiology, diagnosis, therapy and prevention. Virol J (2009) 1.51
Detection of viral DNA in neonatal herpes simplex virus infections: frequent and prolonged presence in serum and cerebrospinal fluid. J Infect Dis (1991) 1.49
Ability of a rapid serology test to detect seroconversion to herpes simplex virus type 2 glycoprotein G soon after infection. J Clin Microbiol (1999) 1.39
The immune response to herpes simplex virus type 1 infection in susceptible mice is a major cause of central nervous system pathology resulting in fatal encephalitis. J Virol (2008) 1.36
Duplex real-time polymerase chain reaction assay for detection and quantification of herpes simplex virus type 1 and herpes simplex virus type 2 in genital and cutaneous lesions. Sex Transm Dis (2004) 1.21
Herpes simplex virus viremia during primary genital infection. J Infect Dis (2008) 1.20
Comparison of diploid fibroblast and rabbit kidney tissue cultures and a diploid fibroblast microtiter plate system for the isolation of herpes simplex virus. J Clin Microbiol (1988) 1.18
Quantitation of viral load in neonatal herpes simplex virus infection and comparison between type 1 and type 2. J Med Virol (2002) 1.15
Rapid localized spread and immunologic containment define Herpes simplex virus-2 reactivation in the human genital tract. Elife (2013) 1.12
Neonatal antibody-dependent cellular cytotoxic antibody levels are associated with the clinical presentation of neonatal herpes simplex virus infection. J Infect Dis (1989) 1.08
Viremia in neonatal herpes simplex virus infections. Pediatr Infect Dis J (1999) 1.08
Neonatal herpes simplex virus infections: HSV DNA in cerebrospinal fluid and serum. Arch Dis Child Fetal Neonatal Ed (1999) 0.98
Herpes simplex viremia: report of eight pediatric cases and review of the literature. Clin Infect Dis (1994) 0.97
Use of blood polymerase chain reaction testing for diagnosis of herpes simplex virus infection. J Pediatr (2012) 0.95
The immunologic basis for severe neonatal herpes disease and potential strategies for therapeutic intervention. Clin Dev Immunol (2013) 0.93
Cost-effectiveness analysis of herpes simplex virus testing and treatment strategies in febrile neonates. Arch Pediatr Adolesc Med (2008) 0.93
Neonatal herpes encephalitis: a case series and review of clinical presentation. Can J Neurol Sci (2003) 0.87
Challenges in the diagnosis and management of neonatal herpes simplex virus encephalitis. Pediatrics (2005) 0.84
Guidance on management of asymptomatic neonates born to women with active genital herpes lesions. Pediatrics (2013) 0.83
Diagnosis of herpes simplex virus in the era of polymerase chain reaction. Pediatr Infect Dis J (2006) 0.83
A hypothesis on the pathophysiology of neonatal herpes simplex virus encephalitis: clinical recurrence after asymptomatic primary infection. Pediatr Infect Dis J (1990) 0.78